Geode Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190M | Buy |
3,474,438
+43,185
| +1% | +$2.37M | 0.01% | 683 |
|
|
2025
Q1 | $242M | Buy |
3,431,253
+142,475
| +4% | +$10M | 0.02% | 578 |
|
|
2024
Q4 | $216M | Buy |
3,288,778
+28,728
| +0.9% | +$1.88M | 0.02% | 612 |
|
|
2024
Q3 | $229M | Buy |
3,260,050
+60,692
| +2% | +$4.26M | 0.02% | 593 |
|
|
2024
Q2 | $263M | Buy |
3,199,358
+212,643
| +7% | +$17.5M | 0.02% | 513 |
|
|
2024
Q1 | $260M | Buy |
2,986,715
+114,283
| +4% | +$9.97M | 0.02% | 521 |
|
|
2023
Q4 | $276M | Buy |
2,872,432
+109,996
| +4% | +$10.6M | 0.03% | 480 |
|
|
2023
Q3 | $244M | Buy |
2,762,436
+51,411
| +2% | +$4.54M | 0.03% | 477 |
|
|
2023
Q2 | $235M | Buy |
2,711,025
+48,902
| +2% | +$4.23M | 0.03% | 497 |
|
|
2023
Q1 | $258M | Buy |
2,662,123
+78,019
| +3% | +$7.58M | 0.03% | 453 |
|
|
2022
Q4 | $267M | Buy |
2,584,104
+69,581
| +3% | +$7.19M | 0.04% | 441 |
|
|
2022
Q3 | $213M | Buy |
2,514,523
+42,707
| +2% | +$3.62M | 0.03% | 463 |
|
|
2022
Q2 | $205M | Buy |
2,471,816
+17,579
| +0.7% | +$1.46M | 0.03% | 488 |
|
|
2022
Q1 | $189M | Buy |
2,454,237
+54,894
| +2% | +$4.23M | 0.02% | 556 |
|
|
2021
Q4 | $212M | Buy |
2,399,343
+76,459
| +3% | +$6.75M | 0.03% | 535 |
|
|
2021
Q3 | $179M | Buy |
2,322,884
+13,962
| +0.6% | +$1.08M | 0.02% | 556 |
|
|
2021
Q2 | $192M | Buy |
2,308,922
+140,877
| +6% | +$11.7M | 0.03% | 547 |
|
|
2021
Q1 | $163M | Buy |
2,168,045
+110,904
| +5% | +$8.36M | 0.03% | 566 |
|
|
2020
Q4 | $180M | Buy |
2,057,141
+69,325
| +3% | +$6.07M | 0.03% | 494 |
|
|
2020
Q3 | $151M | Sell |
1,987,816
-96,620
| -5% | -$7.34M | 0.03% | 473 |
|
|
2020
Q2 | $257M | Buy |
2,084,436
+2,143
| +0.1% | +$264K | 0.06% | 325 |
|
|
2020
Q1 | $176M | Buy |
2,082,293
+146,481
| +8% | +$12.4M | 0.05% | 361 |
|
|
2019
Q4 | $164M | Buy |
1,935,812
+107,612
| +6% | +$9.09M | 0.03% | 457 |
|
|
2019
Q3 | $123M | Buy |
1,828,200
+21,321
| +1% | +$1.44M | 0.03% | 502 |
|
|
2019
Q2 | $155M | Buy |
1,806,879
+52,797
| +3% | +$4.52M | 0.04% | 445 |
|
|
2019
Q1 | $156M | Buy |
1,754,082
+110,575
| +7% | +$9.81M | 0.04% | 426 |
|
|
2018
Q4 | $140M | Buy |
1,643,507
+92,519
| +6% | +$7.87M | 0.04% | 408 |
|
|
2018
Q3 | $150M | Buy |
1,550,988
+22,596
| +1% | +$2.19M | 0.04% | 418 |
|
|
2018
Q2 | $144M | Buy |
1,528,392
+56,446
| +4% | +$5.31M | 0.04% | 410 |
|
|
2018
Q1 | $119M | Buy |
1,471,946
+25,767
| +2% | +$2.09M | 0.04% | 454 |
|
|
2017
Q4 | $129M | Buy |
1,446,179
+19,011
| +1% | +$1.69M | 0.04% | 414 |
|
|
2017
Q3 | $133M | Buy |
1,427,168
+24,328
| +2% | +$2.26M | 0.05% | 373 |
|
|
2017
Q2 | $127M | Buy |
1,402,840
+79,799
| +6% | +$7.24M | 0.05% | 369 |
|
|
2017
Q1 | $116M | Buy |
1,323,041
+73,845
| +6% | +$6.48M | 0.05% | 379 |
|
|
2016
Q4 | $103M | Buy |
1,249,196
+110,575
| +10% | +$9.16M | 0.05% | 381 |
|
|
2016
Q3 | $105M | Buy |
1,138,621
+82,192
| +8% | +$7.6M | 0.05% | 355 |
|
|
2016
Q2 | $82.2M | Buy |
1,056,429
+45,519
| +5% | +$3.54M | 0.04% | 401 |
|
|
2016
Q1 | $83.3K | Buy |
1,010,910
+47,547
| +5% | +$3.92K | 0.04% | 388 |
|
|
2015
Q4 | $101M | Buy |
963,363
+19,214
| +2% | +$2.01M | 0.06% | 323 |
|
|
2015
Q3 | $99.4M | Buy |
944,149
+12,916
| +1% | +$1.36M | 0.06% | 320 |
|
|
2015
Q2 | $127M | Buy |
931,233
+54,043
| +6% | +$7.39M | 0.07% | 278 |
|
|
2015
Q1 | $109M | Buy |
877,190
+96,036
| +12% | +$12M | 0.06% | 315 |
|
|
2014
Q4 | $70.6M | Buy |
781,154
+24,679
| +3% | +$2.23M | 0.04% | 411 |
|
|
2014
Q3 | $54.6M | Buy |
756,475
+13,555
| +2% | +$978K | 0.04% | 453 |
|
|
2014
Q2 | $46.2M | Buy |
742,920
+21,678
| +3% | +$1.35M | 0.03% | 502 |
|
|
2014
Q1 | $49.2M | Buy |
721,242
+43,211
| +6% | +$2.95M | 0.03% | 469 |
|
|
2013
Q4 | $47.6M | Buy |
678,031
+78,584
| +13% | +$5.52M | 0.03% | 464 |
|
|
2013
Q3 | $43.3M | Buy |
599,447
+33,765
| +6% | +$2.44M | 0.03% | 450 |
|
|
2013
Q2 | $31.6M | Buy |
+565,682
| New | +$31.6M | 0.03% | 500 |
|